Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, has signed a letter of intent to acquire a majority stake in an international CRO. The target company operates in Europe, North Africa ...

Cairn Homes Plc announces proposed secondary placing of 3.5 million shares by CEO Michael Stanley via an accelerated bookbuild with Goodbody Stockbrokers UC ...

Carvolix, formerly Affluent Medical, has published its financial results for 2025. The company has undergone a strategic shift towards interventional cardiology with the acquisition of Caranx Medical ...

First Berlin Equity Research has updated its assessment of Deutsche Rohstoff AG, maintaining a BUY recommendation and raising the target price from €86.00 to €139.00. The reason behind this adjustment ...

Covivio announces availability of its 2025 Universal Registration Document in ESEF format, filed with AMF and accessible on its website and AMF's site. Includes financial report, sustainability report ...